FDA is alerting healthcare professionals that Byetta (exenatide) may be associated with acute pancreatitis in some patients. Byetta is administered subcutaneously to treat type 2 diabetes.
FDA has reviewed 30 reports of acute pancreatitis in pat...
Lawyer Central Also Recommends These Stories: